These observations led us to speculate that, in our experimental conditions, the increase in in vitro TNFα levels promoted by EphB4 is a possible consequence of the blockade of EphB forward signaling in splenic mononuclear cells and a result only apparently conflicting with its protective action in TNBS-induced colitis. Here, EPHB4 is linked to colitis.